tirzepatide surmount-1 weight loss percent nejm 2022 SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes Our weight management program: 12

However, their remarkable side effectsignificant weight losshas made them increasingly popular for those seeking a medical approach to managing their weight

Participants were included if they were 18 years of age or older, had a BMI of 30 or higher (or 27 with at least one obesity-related complication), and reported at least one unsuccessful dietary effort for weight loss

As a triple agonist activating GLP-1, GIP, and glucagon receptors, it provides the most comprehensive receptor coverage available

Patients with certain genetic profiles may be more sensitive to metabolic changes, helping your provider personalize your treatment plan and monitoring strategy to protect both physical and mental health

Social eating dynamics change